Skip to search formSkip to main contentSkip to account menu

Lopid

Known as: Lipur, Lopid R 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Gemfibrozil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Measuring Service Quality Expectation and Satisfaction Using Servqual at Hutan Lipur Sungai Congkak
Recreation activity based on recreational forest has risen as one of the important industries in the Malaysia economy. This area… 
2017
2017
LOPID (Gemfibrozil Tablets, USP)
  • 2017
  • Corpus ID: 44822173
DESCRIPTION LOPID (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for oral administration… 
Review
2015
Review
2015
Keintelektualan pemikiran melayu dalam cerita lipur lara:satu penetian awal berdasarkan perspektif pendekatan pengurusan (intelectual malay minds in folklore: initial investigation from the…
This paper explores the scientific and intellectual traditions of Malay civilization in the folklore story based on a new… 
2011
2011
Analysis of Simbolic Meaning of the Space and Layout of Angkul-Angkul of Traditional House in Penglipuran Village-Kubu District, Bangli Regency
Traditional house of Penglipuran, located in Penglipuran traditional village, Kubu district, Bangli regency, is an integrated… 
2004
2004
Cerita lipur lara
2002
2002
Case Study: Atypical Antipsychotic Use Associated With Severe Hyperglycemia
A.T. is a 50-year-old woman who developed acute hyperosmolar crisis. She first presented for primary care 5 months before the… 
1999
1999
Evaluation of kidney and liver subacute toxicity induced by bezalip ‐ pravastatin. Lopid antihyperlipidaemic compounds in rats
Renal and hepatic subacute toxicity induced by the antihyperlipidaemic drugs: Bezalip ‐ Pravastatin and Lopid was investigated in… 
1993
1993
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I.
1991
1991
[Side effects of fibrates (except liver and muscle)].
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… 
1990
1990
Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
In 25 patients with primary dyslipoproteinemias and severe premature atherosclerosis, during an average combined Lopid-Mevacor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)